Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

676
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Technical Review of Magnetic Resonance Fingerprinting Applications in Cerebral Physiology.

Magnetic resonance in medicine·2025
Same author

Machine learning in targeted protein degradation drug design: a technical review of PROTACs and molecular glues.

Drug discovery today·2025
Same author

Fragment Linker Prediction Using the Deep Encoder-Decoder Network for PROTACs Drug Design.

Journal of chemical information and modeling·2023
Same author

Harnessing polyhydroxylated pyrrolidines as a stabilizer of acid alpha-glucosidase (GAA) to enhance the efficacy of enzyme replacement therapy in Pompe disease.

Bioorganic & medicinal chemistry·2022
Same author

Slide-free imaging of hematoxylin-eosin stained whole-mount tissues using combined third-harmonic generation and three-photon fluorescence microscopy.

Journal of biophotonics·2019
Same author

Pathological complete response in pancreatic adenocarcinoma with FOLFIRINOX.

BMJ case reports·2018

Related Experiment Video

Updated: Jun 12, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K

A Novel Rational PROTACs Design and Validation via AI-Driven Drug Design Approach.

Cheng-Li Chou1, Chieh-Te Lin2, Chien-Ting Kao1

  • 1AnHorn Medicines Co., Ltd., Taipei 115202, Taiwan.

ACS Omega
|September 23, 2024
PubMed
Summary

This study introduces an AI-driven approach for designing Proteolysis-targeting chimeras (PROTACs). The method combines structural biology and deep learning to create novel drug candidates with improved binding affinities.

More Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.5K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K

Related Experiment Videos

Last Updated: Jun 12, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.5K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K

Area of Science:

  • Computational chemistry
  • Structural biology
  • Artificial intelligence in drug discovery

Background:

  • Rational drug design, especially for Proteolysis-targeting chimeras (PROTACs), is challenging due to limited structural data and complex molecular bridging requirements.
  • Developing novel small molecules to link proteins of interest (POIs) with ubiquitin-protein ligases (E3s) is critical for PROTAC efficacy.

Purpose of the Study:

  • To develop an integrated computational workflow for generating novel PROTAC molecules with enhanced binding affinities.
  • To leverage deep learning and structural biology techniques to overcome limitations in PROTAC design.
  • To validate the workflow using the cIAP1-BTK ternary complex.

Main Methods:

  • An integrated approach combining superimposition techniques and deep neural networks for molecule generation.
  • Evaluation of protein-ligand pairs using root-mean-square deviation (RMSD), binding free energy (BFE), and buried solvent-accessible surface area (SASA).
  • Inclusion of molecular dynamics (MD) and free energy perturbation (FEP) simulations for quantitative binding energy assessment.

Main Results:

  • Generated novel PROTAC molecules exhibit comparable structural attributes to existing complexes.
  • The novel PROTACs demonstrate superior binding affinities within target binding pockets.
  • Simulations confirmed enhanced affinity for the newly designed linker molecules.

Conclusions:

  • The developed methodology provides an effective workflow for AI-driven drug design, aligning computational predictions with practical limitations.
  • This approach represents a novel paradigm in the design of Proteolysis-targeting chimeras.
  • The validated workflow enhances the generalizability and reliability of computational drug discovery.